Showing results (631-640 of 16,804) with videos related to
Sort By:
Pageof 1,681
British Journal of Haematology|April 1, 2008
Heat shock protein 90 inhibition is cytotoxic to primary AML cells expressing mutant FLT3 and results in altered downstream signallingLaila Al Shaer, Elisabeth Walsby, Amanda Gilkes, et al.British Journal of Haematology|April 4, 2008
Prognostic importance of T and NK-cells in a consecutive series of newly diagnosed patients with chronic lymphocytic leukaemiaShanique Palmer, Curtis A Hanson, Clive S Zent, et al.British Journal of Haematology|April 16, 2008
Venous thromboembolism in hospitalised patients: a public health crisis?Trevor BaglinBritish Journal of Haematology|April 16, 2008
Advances in the understanding of mantle cell lymphomaPedro Jares, Elías CampoBritish Journal of Haematology|April 16, 2008
Prediction of survival using absolute lymphocyte count for newly diagnosed patients with multiple myeloma: a retrospective studyHilmi Ege, Morie A Gertz, Svetomir N Markovic, et al.British Journal of Haematology|April 16, 2008
Developments in the therapeutic use of erythropoiesis stimulating agentsWolfgang JelkmannBritish Journal of Haematology|April 16, 2008
Current status of globin gene therapy for the treatment of beta-thalassaemiaLeszek Lisowski, Michel SadelainBritish Journal of Haematology|June 19, 2008
Clinical and molecular characterisation of a prospectively collected cohort of children and adolescents with polycythemia veraHolger Cario, Klaus Schwarz, Jan M Herter, et al.British Journal of Haematology|April 10, 2025
Hypomethylating agent and venetoclax are effective salvage therapies in relapsed/refractory early T-cell precursor acute lymphoblastic leukaemiaVaibhav Agrawal, Shukaib Arslan, Hoda Pourhassan, et al.British Journal of Haematology|April 8, 2025
Myeloid neoplasm inspired intensive therapy in VEXAS syndrome: A single-centre experienceMaël Heiblig, Adriana Plesa, Juliet Tantot, et al.Pageof 1,681